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Abstract 
Background: Internalizing mental disorders (IMDs) (depression, anxiety and post-traumatic stress disorder) have 
been associated with accelerated telomere length (TL) attrition; however, this association has not been investigated 
in the context of genetic variation that has been found to influence TL. We have previously reported an association 
between IMDs and accelerated TL attrition among Ugandan HIV+ children and adolescents. This study investi-
gated the moderating effects of selected single nucleotide polymorphisms in the telomerase reverse transcriptase 
gene (TERT) (rs2736100, rs7726159, rs10069690 and rs2853669) and the telomerase RNA component gene (TERC) 
(rs12696304, rs16847897 and rs10936599) on the association between IMDs and TL, among Ugandan HIV+ children 
(aged 5–11 years) and adolescents (aged 12–17 years).
Results: We found no significant interaction between IMDs as a group and any of the selected SNPs on TL at base-
line. We observed significant interactions of IMDs with TERT rs2736100 (p = 0.007) and TERC rs16847897 (p = 0.012), 
respectively, on TL at 12 months.
Conclusions: TERT rs2736100 and TERC rs16847897 moderate the association between IMDs and TL among Ugan-
dan HIV+ children and adolescents at 12 months. Understanding the nature of this association may shed light on the 
pathophysiological mechanisms underlying advanced cellular aging in IMDs.
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Background
Human immunodeficiency virus-positive (HIV+) chil-
dren and adolescents suffer a considerable burden of 
internalizing mental disorders (IMDs) (namely, depres-
sion, anxiety and post-traumatic stress disorder) [1–3]. 
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Studies undertaken both in the developed (Europe and 
the United States) and developing world (sub-Saharan 
Africa) among HIV+ children and adolescents have doc-
umented rates of major depressive disorder of between 
12.7 and 40% [2–8], and rates of anxiety disorders of 
between 9 and 32.2% [1–3, 6]. For IMDs combined, rates 
of between 12 and 27% have been documented in Uganda 
and South Africa, respectively [1, 9]. Among people liv-
ing with HIV/AIDS, IMDs have been associated with a 
number of other negative outcomes, including acceler-
ated cellular aging [10], faster HIV disease progression 
[11, 12], poor adherence to medication [12, 13], risky 
sexual behavior [13, 14], poor linkage to care for newly 
diagnosed HIV+ persons [15], increased HIV transmis-
sion (through the promotion of HIV drug resistance) [16] 
and impaired academic and social functioning [13].
While considerable research has investigated the psy-
chosocial risk factors for IMDs among HIV+ children 
and adolescents, there is a paucity of research on bio-
logical risk factors, including genetic factors. Recent 
genome-wide association (GWAS) studies have identified 
loci for depression [17], anxiety disorders [18] and post-
traumatic stress disorder (PTSD) [19, 20], providing evi-
dence for the role of genetic variation in the etiology of 
IMDs. Nevertheless, the etiology of IMDs, and the bio-
chemical and molecular contributions in particular, are 
largely unknown.
IMDs are associated with increased mortality and age-
related diseases, such as cancer, heart and cardiovascu-
lar disease [21–24]. IMDs are also highly comorbid with 
both psychiatric and somatic disorders, including those 
associated with advanced aging [25]. Depression has, for 
example, been reported to be associated with chronic 
diseases (e.g., type 2 diabetes mellitus and cardiovascu-
lar disease) [25, 26], as well as chronic inflammation [27]. 
In addition, higher mortality rates have been reported 
among patients with mental disorders (e.g., depression 
and other affective disorders) compared to the general 
population, with this mortality mainly due to the same 
age-related diseases, such as cancer, cardiac and cerebro-
vascular disease [22–24].
Several studies have investigated the association 
between telomeres, the protein-bound deoxyribonu-
cleic acid (DNA) repeat structures at the ends of chro-
mosomes, and IMDs [28]. Telomeres are important in 
protecting chromosomes from fusing together during 
mitosis, thus preventing loss of genetic data [29, 30]. 
They shorten progressively with each cell division, even-
tually leading to DNA damage responses, replicative 
senescence, or programmed cell death [31]. Since tel-
omeres shorten with each cycle of cell division, telomere 
length (TL) provides a marker of biological aging [32]. 
Evidence for the role of TL  among patients with IMDs 
and comorbid age-related diseases may offer insights into 
a novel potential mechanism for the excess morbidity 
and mortality associated with IMDs [33].
Shorter TL has been reported among patients with 
depression [34–41], anxiety disorders [34, 42, 43] and 
PTSD [44–47]. However, there has been comparatively 
little research into the relationship between TL and IMDs 
in the context of HIV infection, which has itself been 
associated with TL attrition [48, 49]. Shortening of tel-
omeres in seropositive individuals may be due to HIV 
infection-associated increases in inflammatory and oxi-
dative processes, both of which drive TL attrition [50, 51] 
or due to the effect of some nucleoside analogue reverse 
transcriptase inhibitors [50]. Furthermore, HIV-associ-
ated illness and stigma can act as a chronic psychological 
stressor to further drive TL attrition [52, 53].
We previously found evidence to suggest accelerated 
TL attrition that was driven by IMDs among Ugandan 
HIV+ children and adolescents [10]. There is, however, 
a dearth of data on the mechanisms by which IMDs lead 
to TL attrition. IMDs act as chronic stressors [54, 55], 
producing long-lasting biological adaptations that could 
potentially explain TL attrition due to IMDs [56]. Specifi-
cally, chronic stress can exert long-lasting effects on the 
hypothalamic–pituitary–adrenal  (HPA) axis, such that 
previous experience of stress may prime a heightened 
response on subsequent stressor exposure [57]. Chronic 
stress also increases inflammatory signaling, which may 
in turn produce a pro-oxidative environment. Both 
inflammation and oxidative stress have been negatively 
associated with TL [51].
TL is partially heritable, with heritability estimates 
ranging between 44 and 80% [58, 59]. Therefore, genetic 
variation may contribute to telomere maintenance [60] 
and this genetic variation may confer risk for acceler-
ated TL attrition. TL is maintained by telomerase, a 
catalytic enzyme with a protein component encoded by 
telomerase reverse transcriptase gene (TERT) and an 
RNA template component encoded by telomerase RNA 
component gene (TERC). Together, these act to add small 
DNA repeat segments to the end of chromosomes, thus 
counteracting TL attrition [30, 61]. A large genome-wide 
meta-analysis of 37,684 individuals found that TERT and 
TERC were amongst several loci found to influence mean 
TL [60], suggesting that genetic variation in these telom-
erase components has functional implications on TL.
The TERC rs12696304 G-allele and rs16847897 C-allele 
have been found to be associated with shorter TL by a 
candidate gene study on Swedish samples and a GWAS 
study on British samples [62, 63]. In addition, the TERT 
rs2736100 C-allele has been associated with shorter TL 
[60], while TERT rs7726159 AA genotype was associated 
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with longer TL by a candidate gene study using White 
European samples [64].
We have previously determined an association 
between IMDs and TL in a sample of Ugandan HIV+ 
children and adolescents [10]. Specifically, TL was sig-
nificantly longer in IMDs cases at baseline but did not 
differ from control TL at 12-month follow-up, suggest-
ing that TL shortening over the one-year period was 
greater in participants with IMDs. Given that TERT and 
TERC are involved in TL maintenance [30], the present 
study investigated whether genetic variation in TERT 
(rs2736100, rs7726159, rs10069690 and rs2853669) and 
TERC (rs12696304, rs16847897 and rs10936599) mod-
erated the association between IMDs and baseline and 
12-month TL. Having observed that IMDs were driving 
accelerated TL attrition in the previous study [10], we 
modelled IMDs as the independent variable and TL as 
the dependent variable. We thus assessed for the inter-
action between IMDs and TERT and TERC on TL.
Methods
Study design
This case–control study was carried out in children (aged 
5–11  years) and adolescents (12–17  years). A total of 
368 cases with any internalizing mental disorder (IMD) 
and 368 age- and sex-matched controls were included. 
Both cases and controls were Ugandans. This study was 
nested within the previously described CHAKA study [1, 
65], which enrolled 1339 HIV+ children and adolescents 
(855 children and 484 adolescents) in Uganda. This study 
complied with the Code of Ethics of the World Medical 
Association (Declaration of Helsinki). The CHAKA study 
obtained ethical and scientific clearance from the Uganda 
Virus Research Institute (UVRI) Science and Ethi-
cal Committee (#GC/127/15/06/459) and the Uganda 
National Council of Science and Technology (# HS 1601). 
The present study obtained approval from the Higher 
Degrees Research & Ethics Committee, School of Bio-
medical Sciences, College of Health Sciences, Makerere 
University (# SBS 421) and the Health Research Ethics 
Committee of Stellenbosch University (#S17/09/179). 
Study subjects who were diagnosed with significant psy-
chiatric problems were referred to mental health units at 
Entebbe and Masaka government hospitals.
Study population
Study subjects were recruited from two HIV clinics in 
urban Kampala (Joint Clinic Research Centre (JCRC) 
and Nsambya Home Care) and three HIV clinics in 
rural Masaka (The AIDS Support Organization (TASO), 
Kitovu Mobile Clinic and Uganda Cares). All study sub-
jects were on anti-retroviral therapy (ART).
Selection of cases and controls
Cases were all participants in CHAKA who met criteria 
for diagnosis of any IMD at baseline as per the diagnos-
tic and statistical manual of mental disorders-edition 
5 (DSM-5) referenced Child and Adolescent Symptom 
Inventory-5 (CASI-5) [66]. All cases at baseline were 
ascertained, and the cases were then stratified by site 
(one of two sites), sex, age category (one of three cat-
egories) and socio-economic status (SES) (one of three 
SES categories). This resulted in a total of 36 strata 
(2 × 2 × 3 × 3). In each stratum the number of cases was 
ascertained (e.g. for males in site 1 in the youngest age 
category and the lowest SES group there were 9 cases). 
An equal number of controls (HIV+ children and ado-
lescents without any psychiatric disorder) were then ran-
domly sampled from the stratum concerned (so for males 
in site 1 in the youngest age category and the lowest SES 
group we sampled 9 controls), thus the controls were fre-
quency matched to the cases on site, sex, age and SES.
Inclusion and exclusion criteria
Inclusion criteria: (1) HIV-infected outpatients, regis-
tered with the HIV Clinics at JCRC or Nsambya Home 
Care at the Kampala study site and TASO, Kitovu 
mobile or Uganda Cares clinic at the Masaka site; (2) 
aged between 5 and 17  years at the time of enrolment; 
(3) conversant in English or Luganda, the language into 
which the assessment tools were translated; and (4) able 
to provide written informed consent/assent. Cases were 
HIV+ children and adolescents who had any depressive 
disorder (depression or dysthymia [persistent depres-
sive disorder]), anxiety disorder or PTSD. Controls were 
age- and sex- matched HIV+ children and adolescents 
without any psychiatric disorder. Persistent IMDs were 
baseline cases that remained cases at 12  months while 
remitted ones were baseline cases that no longer quali-
fied for a diagnosis at 12 months. Exclusion criteria: (1) 
seriously ill and unable to understand study procedures; 
and (2) any other psychiatric disorder other than the 
IMDs listed above.
Procedures
As part of the CHAKA study, children and assenting 
adolescents, as well as their parents/caregivers, were 
interviewed using a structured questionnaire. The ques-
tionnaire included, amongst others, socio-demographic 
characteristics and depression, PTSD and anxiety mod-
ules of the DSM-5 [66]. The CASI-5 was administered by 
trained psychiatric nurses or psychiatric clinical officers 
at two time points (baseline and 12 months). The CASI-5 
lists the symptoms of a wide range of psychiatric disor-
ders including MDD, generalized anxiety disorder, PTSD 
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and attention-deficit/hyperactivity disorder among oth-
ers. Individual CASI-5 items are rated on a four-point 
frequency of occurrence scale ranging from never (0) to 
very often (3). Though there are several CASI-5 scoring 
algorithms, in the present study we used symptom count 
cut-off scores, which reflect the prerequisite number of 
symptoms for a clinical diagnosis. At each study visit, 
4 ml of blood from each study participant was collected 
via venipuncture into an EDTA vacutainer and subse-
quently stored at −  80  °C pending DNA extraction for 
genetics analyses.
Determination of genotypes for selected polymorphisms 
in telomerase reverse transcriptase gene and telomerase RNA 
component gene
DNA samples were genotyped for each selected SNP in 
each of TERT (rs2736100, rs7726159, rs10069690 and 
rs2853669) and TERC (rs12696304, rs16847897 and 
rs10936599), using a kompetitive allele-specific PCR 
(KASP) assay (LGC, Middelsex, United Kingdom). This 
genotyping chemistry allowed for bi-allelic discrimina-
tion of SNPs. The genotyped SNPs in each of TERT and 
TERC were analyzed for linkage disequillibrium (LD) by 
creating an LD map using the default Gabriel LD [67], 
implemented in Haploview software, version 4.2 [68]. For 
SNPs that were in LD, haplotypes were generated using 
the Haploview software.q
Power of the study
Using results from a study by Epel et  al. [69], post hoc 
power calculations (described in [10]) indicated that our 
study was well-powered with 83.8% power to detect at 
least 5% reduction in mean TL between cases and con-
trols. For the interaction analysis, assuming a type I error 
rate of 0.05, zero correlation of the outcome between 
cases and controls, 1.6 odds ratio of exposure in cases rel-
ative to controls, a 0.055 probability of exposure among 
controls and a 1:1 case: control ratio for 368 cases, our 
interaction analyses achieved a power of 87.5%.
Statistical methods
Statistical analyses were conducted using Stata 15 
(StataCorp, TX, USA). Socio-demographic characteris-
tics (including socio-economic status) were compared 
between cases and controls. Socio-economic status (SES) 
was generated from a scale of 9 household items owned 
(car, motorcycle, refrigerator, electricity, bicycle, radio, 
telephone, cupboard and flask). Each item was weighted 
in the respective order, a car carrying a maximum weight 
of 9 and a flask a minimum weight of 1. A total score of 
items was generated, whose median cut-off of 13 was 
used to classify low and high SES. A score less than 13 
was classified as low SES, while that greater than 13 was 
classified as high SES. Our study group [70] has previ-
ously used household items as a measure of SES in rural 
settings of Uganda. A t-test was used to compare CD4 
counts between cases and controls to account for any dis-
parity in HIV disease progression.
Associations between the different socio-demographic 
factors and TL were tested using one-way analysis of 
variance (ANOVA) to determine potential confound-
ers. Independent sample t-tests were used to assess the 
association between IMDs and TL both at baseline and 
12  months. TERT and TERC genotypes were assessed 
for HWE using a likelihood ratio test. The genotypes 
were not validated as genotyping was done by a service 
provider using an automated SNP genotyping array. 
One-way ANOVA was used to assess for the association 
between each of the investigated SNPs or haplotype with 
baseline and 12  months TL, as well as the TL change. 
A likelihood ratio test was used to assess for interac-
tion between each of the polymorphisms and IMDs on 
TL both at baseline and 12  months controlling for age 
and sex, with Bonferroni corrections for multiple test-
ing. The likelihood ratio test was also used to assess for 
interaction between the generated TERT rs2736100-
rs7726159 haplotypes and IMDs on TL both at baseline 
and 12  months controlling for age and sex as well. To 
perform a Bonferroni correction, the p value threshold 
of 0.05 was divided by 2 (number of separate tests) to 
yield a corrected threshold p value of 0.025. These inter-
actions were performed on all the explanatory variables 
even without observing significant main effects in order 
to rule out the possibility of cross over interaction where 
significant interactions may be observed for non-signif-
icant main effects. For significant interactions, mean TL 
at 12 months was plotted against genotypes to elucidate 
the nature of the interaction terms. Where required, 95% 
confidence intervals were calculated.
Results
No significant differences were observed when socio-
demographic variables were compared between case and 
control participants (Table 1).
The genotypes for all the selected SNPs were in Hardy–
Weinberg equilibrium (HWE) (Table  2). None of TERC 
SNPs were in linkage disequilibrium (LD). However, 
TERT rs7726159 and rs2736100 were in LD, resulting in 
CT, CG and AG haplotypes (see Additional file 1: S1 and 
S2). The genotype frequencies for all the selected SNPs 
and the TERT rs2736100-rs7726159 haplotype freqen-
cies are shown in Additional file 1: Table S1. The associa-
tion between each investigated SNP and TL are shown in 
Table  2 below. None of the selected SNPs or the TERT 
rs2736100-rs7726159 haplotypes associated with base-
line or 12  months TL or TL change; however, TERC 
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16847897 significantly associated with 12-month TL 
(Table 2).
Moderating effects of single nucleotide polymorphisms 
in telomerase reverse transcriptase gene and telomerase 
RNA component gene on the association 
between internalizing mental disorders and telomere 
length
We found no moderating role for any of the selected 
SNPs and on the association between IMDs and TL at 
baseline (Table 3). We did find that TERT rs2736100 and 
TERC rs16847897 significantly moderated the associa-
tion between IMDs and TL at 12 months (p = 0.007 and 
p = 0.012 respectively) (Table  3). For TERT rs2736100, 
mean TL was longer among cases as compared to con-
trols, but only in those individuals with the GG genotype 
(n = 139; 82 cases, 57 controls) (Fig. 1). No significant dif-
ference in TL was observed between cases and controls 
who possessed either the TG (n = 330) or TT (n = 201) 
genotypes (Fig. 1). For TERC rs16847897, mean TL was 
longer in cases compared to controls, but only in individ-
uals with the CC genotype (n = 44; 27 cases, 17 controls) 
(Fig.  1). No significant difference in TL was observed 
between cases and controls who possessed either the 
GC (n = 265) or GG (n = 373) genotypes (Fig. 1). None of 
the TERT rs2736100-rs7726159 haplotypes significantly 
moderated the association between IMDs and TL at 
either baseline (p = 0.379) or 12 months (p = 0.418).
Discussion
Using the same samples of Ugandan HIV+ children and 
adolescents, we previously found that TL was longer 
at baseline in cases with IMDs, but that this difference 
did not remain 12  months later [10]. The present study 
built on those results and investigated whether selected 
polymorphisms within TERT and TERC interacted with 
IMDs to influence baseline and 12  months TL among 
the study participants. We found that TERT rs2736100 
and TERC rs16847897 significantly moderated the asso-
ciation between IMDs and TL at 12  months. To our 
knowledge, this is the first sub-Saharan African study to 
investigate these interactions among HIV+ children and 
adolescents.
Telomeres are maintained by the telomerase enzyme, 
an enzyme whose catalytic protein component and RNA 
template is encoded by TERT and TERC, respectively 
Table 1 Distribution of socio-demographic factors in cases 
and controls
CD4: cluster of differentiation 4; primary = 0–7 years of formal education; 
secondary = 8–14 years of formal education; low socioeconomic status = 0–13; 
high socio-economic status =  > 13 (see statistical methods section). All numbers 
that do not add up were due to missing data
Variable (n) Case n (%) Control n (%) p value
Sex p = 0.111
 Male (342) 160 (43.6) 182 (49.5)
 Female (393) 207 (56.4) 186 (50.5)
Site p = 0.941
 Urban (415) 208 (56.5) 207 (56.3)
 Rural (321) 160 (43.5) 161 (43.7)
Age p = 0.374
 5–11 years (389) 202 (57.6) 187 (54.2)
 12– 17 years (307) 149 (42.4) 158 (45.8)
Education level p = 0.371
 No formal education (13) 9 (2.5) 4 (1.1)
 Primary (648) 323 (88.0) 325 (88.8)
 Secondary (72) 35 (9.5) 37 (10.1)
Socio-economic status p = 0.459
 Low (332) 171 (46.5) 161 (43.8)
 High (404) 197 (53.5) 207 (56.2)
Mean CD4 count at baseline 947.04 944.02 p = 0.939
Table 2 p values for  Hardy–Weinberg equilibrium and  association of  each selected single nucleotide polymorphism 
and the generated haplotypes with telomere length 
HWE: Hardy–Weinberg equilibrium; TERC: telomerase RNA component gene; TERT: telomerase reverse transcriptase gene; TERT rs2736100-rs7726159: TERT rs2736100 
and rs7726159 haplotype; N/A: not applicable
Single nucleotide polymorphism p value of association with HWE p value
Baseline TL 12 months TL TL change
TERC rs16847897 0.650 0.014 0.393 0.461
TERC rs12696304 0.861 0.991 0.981 0.443
TERC rs10936599 0.406 0.142 0.510 1
TERT rs2736100 0.300 0.366 0.581 0.091
TERT rs2853669 0.438 0.507 0.591 0.798
TERT rs7726159 0.590 0.855 0.802 0.882
TERT rs10069690 0.567 0.831 0.802 0.274
TERT rs2736100-rs7726159 0.331 0.724 0.725 N/A
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[30, 61]. Given the role that TERT and TERC play in 
the structure of telomerase [71, 72], variations in genes 
encoding these components could influence TL. How-
ever, none of the investigated polymorphisms signifi-
cantly influenced the association between IMDs and TL 
at baseline. We found a significant interaction between 
IMDs and TERT rs2736100 and TERC rs16847897 on 
TL at 12  months. This interaction points to a possible 
direct influence of IMDs on TL shortening. It is possible 
that chronic pathophysiological processes characteristic 
of IMDs, including inflammation, oxidative stress and 
HPA axis dysregulation [73], produced a cumulative bur-
den over the one-year study period, with the resultant 
increase in allostatic load driving TL attrition. Plots of 
the interaction between IMDs and TL reveal that reduc-
tions in 12-month TL in cases are limited to participants 
carrying the TERT rs2736100 GT or TT genotype. Simi-
larly, for TERC rs16847897, the GC or GG genotypes 
are associated with reduced TL at 12  months. These 
genotypes appear to accelerate TL attrition. However, it 
is hard to tease out the true effects of the genotypes on 
TL attrition in the present study, since the reduction in 
TL after 12 months was strongly significant in both cases 
and controls (p < 0.001 respectively), possibly due to the 
short 12 month period. Future studies with a longer study 
period are required to confirm our findings.
Although the functionality of these two SNPs is not well 
known, data from previous studies strongly suggest their 
involvement in disease-associated TL attrition (sporadic 
idiopathic pulmonary fibrosis), as well as pathophysi-
ological mechanisms, such as inflammation, that are rele-
vant to IMDs [74–76]. TERT rs2736100 is located within 
intron 2 of TERT, a position that has been described to 
be a putative regulatory region [77]. TERT rs2736100 has 
also been reported as a critical factor in TERT synthesis 
and activation [63]. TERT rs2736100 has previously been 
associated with diseases characterized by TL attrition, 
including lung cancer [78] and sporadic idiopathic pul-
monary fibrosis [75, 76, 79]. TERT has also been reported 
to interact with natural factor kappa B (NF-κb) p65, 
where it activates NF-κb and increase metalloproteinases 
Table 3 Two-way analysis of  variance for  the  interaction 
of  internalizing mental disorders with  rs2736100 
and with s16847897 on telomere length at 12 months
SNP: single nucleotide polymorphism; Obs: number of observations; IMDs * 
rs2736100: interaction of internalizing mental disorders with TERT rs2736100 on 
relative telomere length; IMDs * TERC rs16847897, interaction of internalizing 
mental disorders with rs16847897 on relative telomere length; *significant p 
value for the interaction term
SNP Obs Variable F Bonferroni corrected 
p value (α = 0.025)
Baseline
 rs2736100 596 IMDs 15.52  < 0.001
rs2736100 0.98 0.375
IMDs * rs2736100 1.15 0.318
 rs16847897 597 IMDs 2.53 0.112
rs16847897 0.37 0.692
IMDs * rs16847897 1.79 0.168
12 months
 rs2736100 511 IMDs 6.03 0.014
rs2736100 0.44 0.645
IMDs * rs2736100 4.95 0.007*
 rs16847897 515 IMDs 7.25 0.007
rs16847897 3.00 0.050
IMDs * rs16847897 4.44 0.012*
Fig. 1 Mean TL between cases and controls by genotype for TERT rs2736100 and TERC rs16847897 at 12 months. For TERT rs2736100 mean TL 
was significantly different between cases and controls, but only in individuals with the GG genotype while for TERC rs16847897, mean TL was 
significantly different between cases and controls but only in individuals with CC genotype
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in cancer cells [74]. On the other hand, TERC 16847897 
has also been reported as locus that could probably regu-
late TL. In line with findings of the present study, each 
copy of the TERC rs16847897 major G-allele (CG or GG) 
was associated with shorter mean TL in a Han Chinese 
population [80]. However, TERC rs16847897 CC geno-
type has also been associated with both shorter TL and 
lower TERT levels [81]. We have no direct explanation 
for this discrepancy. However, it is important to note that 
our findings result from a longitudinal interaction of the 
SNP with IMDs. The nature of this interaction needs to 
be elucidated in order to draw conclusions.
TERT rs2736100 and TERC rs18647897 loci appear 
to have regulatory functions and require further study. 
Although the nature of the interaction between IMDs 
and TERT and TERC on TL is not known, IMDs have 
been associated with increased oxidative stress [82, 
83] and inflammatory markers, such as C-reactive pro-
tein  and the pro-inflammatory cytokines interleukin-6 
and tumor necrosis factor alpha [84, 85]. Oxidative stress 
leads to TL shortening through the inhibition of telomer-
ase activity [73, 86, 87]. We hypothesize that IMD-related 
increases in oxidative stress and inflammatory responses 
produce a cumulative pathophysiological burden. The 
effect of this on TL may potentially be influenced by 
genetic variation in TERT and TERC.
Our study presents with limitations which deserve 
mention. First, the relationships between TL, IMDs and 
HIV are complex and, to a degree, reciprocal. HIV/AIDS 
may shorten TL via both infection-related pathophysio-
logical processes (inflammation and oxidative stress), and 
its capacity to act as a chronic psychological stressor [52, 
53]. Our study participants were also on ART, with some 
regimens, such as Effavirenz, reported to have psychiatric 
side effects [88]. Second, as we did not include an HIV- 
control group in our study, we can only speculate on the 
external validity of our findings. Nevertheless, since our 
results indicate that IMDs drive accelerated TL attrition 
[10], the SNP x IMD interactions observed in this study 
are potentially relevant to other populations. Further 
research would be required to investigate whether these 
findings are generalizable to Ugandan youths in the gen-
eral population as well as other youth populations.. Third, 
we defined our cases as those individuals diagnosed with 
depressive disorder, any anxiety disorder or PTSD. The 
inclusion of PTSD (n = 60) in this sample is contentious, 
as the disorder has recently been excluded from the cat-
egorization of anxiety disorders in the DSM-5 [89]. This 
may have affected our findings. In order to elucidate 
the independent contribution of each particular disor-
der, future studies should analyze each IMD separately. 
Fourth, we did not control for population stratification 
at analysis since the study participants belonged to the 
Bagandan population group for which principal compo-
nents analysis on GWAS data of a sample of over 4,000 
individuals has shown that they are genetically similar, as 
principal components 1 and 2 have been reported to have 
explained only 0.3% and 0.1% of the genetic variation in a 
Bagandan general population cohort [90]. However, there 
is a possibility that some participants may not have been 
Baganda although they identified as Baganda and their 
inclusion could have caused population admixture that 
could have led to spurious results. Future studies should 
endeavor to control for population stratification.
Despite the limitations, our study has strengths that are 
worth mentioning. First, the study sample size was large 
enough (368 cases and 368 controls) to allow a sufficient 
power of greater than 80% for the association between 
IMDs and TL. Second, we measured TL at baseline and 
12 months, a longitudinal aspect that allowed us to assess 
for causation. Third, TL undergoes a period of rapid attri-
tion in the first five years of life, which is followed by rela-
tive stability until young adulthood [91, 92]. As our study 
participants ranged in age from 5 to 17 years and thus fell 
into this period of expected TL stability, the differences 
we identified are more likely to reflect valid influences of 
SNPs and IMDs, as opposed to chronological age effects.
Conclusions
We observed that TERT rs2736100 and TERC 
rs16847897 produce effects on 12-month TL in Ugan-
dan HIV+ children and adolescents diagnosed with 
IMDs. The mechanisms through which TERT and TERC 
SNPs interact with IMDs to influence TL are not known. 
Understanding these mechanisms may help to unravel 
the biochemical processes that take place following onset 
of IMDs, which may aid the discovery of new drugs or 
drug targets for better management of these disorders. 
Furthermore, these mechanisms may also provide insight 
into the biochemical processes that underlie the comor-
bidity between IMDs, age-related conditions and meta-
bolic diseases. Future functional studies are required to 
understand how TERT and TERC SNPs moderate the 
association between IMDs and accelerated TL attrition.
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